Cautious optimism on IPF in new position statement


New antifibrotic drugs have revolutionised the management of idiopathic pulmonary fibrosis but it remains a progressive and fatal disease that requires people to prepare for the worst, according to a new position statement from the Thoracic Society of Australia & New Zealand and the Lung Foundation. Published in the MJA, [link after embargo] the position ...


Already a member? Login to keep reading


OR
© 2018 the limbic